Navigation Links
Astute Medical, Inc. organizará el 33. simposio anual en el congreso ISICEM sobre daño renal
Date:3/13/2013

SAN DIEGO, 14 de marzo 2013 /PRNewswire/ -- El daño renal agudo (DRA) está aumentando en todo el mundo y afecta a millones de pacientes hospitalizados cada año. Líderes en cuidados intensivos comentarán técnicas innovadoras para evaluar el riesgo de DRA en un simposio educativo que se celebrará el miércoles 20 de marzo de 2013 a las 12:30 durante el 33.º simposio internacional sobre Cuidados Intensivos y Medicina de Urgencias (ISICEM, Intensive Care and Emergency Medicine) en Bruselas (Bélgica). Los participantes interesados pueden visitar AKIAssessment.com para registrarse en línea. Los participantes en el evento y otras personas interesadas podrán seguir el evento a través de Twitter @ACuteKidneyMan.

El Dr. John Kellum de la Universidad de Pittsburgh examinará la patogénesis delDRA, presentará las últimas investigaciones [VER ESTUDIO] y destacará dos biomarcadores que han resultado ser muy precisos en la evaluación del riesgo de DRA [VÍDEO] y mejores que los métodos actuales. El Dr. Lakhmir Chawla de la Universidad George Washington y el Dr. Andrew Shaw del centro médico de la Universidad Duke comentarán los biomarcadores de la restricción del ciclo celular en el DRA, así como las implicaciones prácticas para su tratamiento.

Cada vez más, los médicos de los hospitales de todo el mundo están expresando su preocupación sobre los riesgos para la salud y la carga de los costes del DRA .

"Con una incidencia similar a la del infarto de miocardio y con una elevada tasa de mortalidad, el ataque renal debería considerarse
'/>"/>

SOURCE Astute Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Astute Medical, Inc. Advancing Next Generation Acute Kidney Injury Biomarkers
2. Astute Medical, Inc. promuove lultima generazione di biomarcatori per lesioni renali acute
3. Astute Medical, Inc. ospiterà il simposio sullinsufficienza renale al 33o incontro annuale ISICEM
4. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
5. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
6. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Cover in the Medical, Dental & Related Services/Trade Category
7. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Overall Category in Medical, Dental & Related Services/Trade
8. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
9. Saladax Biomedical, Inc. Announces the Formation of a CLIA Laboratory As Part of the Companys Commercialization Strategy
10. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
11. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Revolutionary Science, the manufacturer of the ... that they have expanded their colony counter product line ... InCount and ImpressCount. These affordable colony counters that ... food microbiology and pharmaceutical manufacturing. , The previously released ... bright white enclosure with jet black accents represent the ...
(Date:5/21/2013)... 21, 2013 Vital Imaging ™ ... of California, San Diego for a joint study which ... MRI (Magnetic Resonance Imaging) with that of a supine ... continued pursuit of improved healthcare by combining cutting edge ... an extremely valuable tool for evaluating pathological changes in ...
(Date:5/21/2013)... 2013 PathoGenetix, Inc., a commercial-stage developer ... announced today that it has successfully identified and strain ... obtained from the Centers for Disease Control and Prevention ... The findings are detailed in a poster ... for Microbiology in Denver on Monday. , The 250 ...
(Date:5/20/2013)... MELBOURNE, Australia , May 20, 2013 ... of Agriculture,s (USDA) Agricultural Research Service (ARS) in ... market opportunity , Trials to begin ... Australian drug delivery technology company Phosphagenics Limited ... U.S. Department of Agriculture,s (USDA) Agricultural Research Service (ARS) ...
Breaking Biology Technology:Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Phosphagenics Signs Research Agreement with the Agricultural Research Service 2
... (OTC Bulletin Board: ARNI), today announced that its ... changed from "LRRI.OB" to "ARNI.OB",effective July 17, 2008., ... is a clinical-stage biopharmaceutical company,that develops and commercializes ... lead compound is AR-67, a novel, third-generation,camptothecin analogue ...
... TOKYO, and NEW DELHI, India, July 17 ... media and the stock market, Daiichi Sankyo,Company, ... Laboratories,Limited (NSE/BSE: Ranbaxy/500359) ("Ranbaxy") reiterate that the ... family, the largest,controlling shareholders of Ranbaxy, is ...
... Supply Solutions(R),a focus area within SAFC(R), a ... today that the Company has launched a ... with their regulatory,requirement under the new European ... Authorization and restriction of Chemicals,(REACH) http://www.safcsupplysolutions.com/reach ...
Cached Biology Technology:Arno Therapeutics Announces New Ticker Symbol 2Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation 2SAFC Supply Solutions Launches REACH-Compliant Products and Support 2SAFC Supply Solutions Launches REACH-Compliant Products and Support 3
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... insects provide the white noise of the South, but the ... the Southern air hangs heavy from the humidity and the ... than 140 species of frogs, toads and salamanders, is the ... ponds and swamps are the auditorium for their symphonic choruses, ... Monitoring Initiative, or ARMI, have front-row seats. , ...
(Date:5/17/2013)... China---- Why Tibetan antelope can live at elevations ... collaborative research published in Nature Communications , ... provide evidence that some genetic factors may be ... environments. The data in this work will also ... the biology of other ruminant species. , The ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... smallest possible scales using molecules and individual atoms ... challenging. An interdisciplinary team of researchers at the University ... selecting the best of these blocks, drawing inspiration from ... The team was led by postdoctoral fellow Gevorg ...
... Institute scientists has found a key biological mechanism underpinning ... door to the development of drugs to manage excessive ... much of our lab,s research, was to examine the ... drinking driven by the aversive aspects of alcohol withdrawal," ...
... Bethesda, MDIf you are one of the millions of ... good news is on the way. A new research discovery ... https://www.jleukbio.org ) offers hope for new drugs that treat the ... because the research is the first to identify natural killer ...
Cached Biology News:Penn researchers help nanoscale engineers choose self-assembling proteins 2Penn researchers help nanoscale engineers choose self-assembling proteins 3Scripps Research scientists find key mechanism in transition to alcohol dependence 2Scripps Research scientists find key mechanism in transition to alcohol dependence 3Harvard scientists 'see' the early cellular cause of dry eye disease for the first time 2
Rabbit polyclonal to Myosin VIIa (rating: *****) ( Abpromise for all tested applications). entrezGeneID: 4647 SwissProtID: Q13402...
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
6-keto Prostaglandin F1α EIA Antiserum 6-keto-PGF1alpha EIAs prostaglandins antisera enzyme immunoassays reagents 6-keto-PGF1.alpha....
...
Biology Products: